Parkinson's Disease Trial, Recruiting NCT06685744 Sponsor: Fondazione Don Carlo Gnocchi ETS Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT06685744
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with probable Parkinson's disease (at a mild to moderate stage) or Multiple Sclerosis (at a relatively low level of disability, as measured by a standard disability scale called the EDSS, with a score of 4.5 or below)
  • People aged between 25 and 85 years
  • People whose thinking and memory abilities are above a certain level, as measured by a standard test called the MoCA (score above 15.5)
  • People who are not currently taking part in any other rehabilitation programme at the time of joining
  • People whose medication has been stable for at least the past three months — this includes Parkinson's medications (L-Dopa or dopamine agonists) or Multiple Sclerosis disease-modifying therapies

Who may not be able to join:

  • People who have other serious health conditions that could make a home exercise programme unsafe or cause medical instability (for example, severe joint or bone problems, or severe memory and thinking difficulties)
  • People who have a significant psychiatric illness or a diagnosed personality disorder
  • People who have severe problems with their vision or hearing
  • People who have had a fall that caused an injury, or who have had more than two falls in the six months before joining the trial
  • People who are pregnant
  • People with Multiple Sclerosis who are currently experiencing a relapse, or who have had a relapse within the past three months
  • People with Parkinson's disease who experience frequent "freezing" episodes (a sudden inability to move), as measured by a standard scale called the UPDRS (score of 3 or higher in the relevant section)
  • People with Multiple Sclerosis who have a cerebellar function score of 3 or higher on a specific part of the EDSS disability scale (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 00390240308952

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fondazione Don Carlo Gnocchi ETS
Registry
ClinicalTrials.gov
Start date
23 October 2024
Est. completion
30 May 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Change in static and dynamic balance as measured by the Mini-Best Test

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov